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Analysis of Factors Influencing the Generation of  
Unqualified Clinical Samples and Measures to Prevent 
this Generation
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Department of Laboratory Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing, P.R. China
Background: We investigated the influence of pre-analytical factors on the results of clini-
cal tests and thereby analyzed approaches to improve quality management in clinical lab-
oratories.
Methods: Unqualified clinical samples were selected from all the samples received at our 
clinical laboratory. The data were collected for 2009 and 2010, i.e., the years before and 
after the establishment of the laboratory quality management system. The rate and causes 
of generation of unqualified samples were analyzed, and measures to improve the labora-
tory practices were studied and implemented.
Results: A total of 1,051 unqualified samples were identified from among the 553,158 
samples (the overall incidence rate of unqualified samples was 0.19%). The number of 
unqualified samples substantially varied according to the nature of the sample, and clini-
cal samples collected for routine blood tests or coagulation tests were the predominant 
unqualified samples. The main causes of generation of unqualified samples were insuffi-
cient sample volumes and improper methods of mixing the samples. The rate of genera-
tion of unqualified samples decreased significantly after the implementation of improve-
ment measures (0.26% in 2009 vs. 0.13% in 2010, P<0.001).
Conclusions: The number of unqualified samples decreased significantly after the estab-
lishment of the laboratory quality management system, which promoted active communi-
cation among and training of the clinical staff to reduce the occurrence of pre-analytical 
errors. Comprehensive control of pre-analytical factors is an important approach in im-
proving the clinical laboratory practices.
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INTRODUCTION
In the recent years, the importance of transparency in customer 
service and organizational administration has grown in many 
fields, including administration of medical institutions. Ensuring 
proper communication with patients and transparency in medi-
cal activities have become essential in this regard. International 
Organization for Standardization (ISO) 15189, which specifically 
applies to clinical laboratories, is an international standard is-
sued in 2003. This standard has been commonly employed as 
an accreditation tool for clinical laboratories in China, Europe, 
Australia, Japan, etc. Quality programs in clinical laboratories 
traditionally focused on the processes under direct control of 
the laboratories, particularly in the analytical phase. However, 
most errors occur during pre- and post-analytical phases [1-4], 
which reflects the requirement of extensive quality control in 
ISSN 2234-3806 • eISSN 2234-3814 Lai X, et al.
Reason analysis for unqualified clinical samples
217 http://dx.doi.org/10.3343/alm.2012.32.3.216 www.annlabmed.org
these phases. 
  Since errors and problems are prevalent in the pre-analytical 
phase of diagnostics, this phase is the most critical phase with 
much scope for improvement. However, there have been few 
improvements in this phase, and some testing errors occur in 
the pre-analytical phase [5]. Therefore, reducing the number of 
unqualified samples would contribute to quality management in 
clinical laboratories. The most effective way to avoid any other 
type of medical errors is to implement a complete quality man-
agement system. We recognized the difficulty in controlling er-
rors in the pre-analytical phase during our preparation for the 
surveillance tests for ISO15189 accreditation. Therefore, in this 
study, we analyzed the reasons for these errors and identified 
effective measures that would lead to significant improvements 
in the clinical laboratory quality management system and in 
clinical laboratory practices. 
METHODS
1. Materials
The ISO15189: Pre-examination procedures include the requi-
sites for manual collection of primary samples, traceability of the 
primary samples to an identifiable individual, sample monitoring 
during transport, recording of receipts of samples, and process-
ing of urgent samples [6, 7]. In the study, we defined unquali-
fied samples on the basis of some critical analytical activities, 
such as the accuracy of patient identification, incorrect sample-
collection procedures (for example, use of unsuitable samples 
for microbiologial analysis and hemolysis and clotting of blood 
samples), and insufficient sample volume. The use of inappro-
priate containers was observed to be particularly high for inpa-
tient samples, and this was observed to yield unqualified sam-
ples in the pre-analytical phase [8-10]. The study was conducted 
according to a format, including the reason of unqualified sam-
ples, information on the clinical department that collected the 
sample, and information on the nurse who received the unquali-
fied samples. The laboratory information system (LIS) automati-
cally recorded the data for the total number of samples col-
lected at our clinical laboratory. Information about the unquali-
fied samples was recorded by laboratory technicians who were 
usually in charge of sample collection. We obtained all the infor-
mation and records for the period from 2009 to 2010.
2. Methods
A descriptive study was performed using 1,051 unqualified sam-
ples obtained at the department of laboratory medicine in a teach-
ing hospital between 2009 and 2010. The data collection forms 
were created in January 2010, and the modified form was used 
for 11 months (from January 2010 to December 2010) to collect 
the baseline data of samples that were processed completely in 
the clinical laboratory. All the data were analyzed using the Sta-
tistical Package for the Social Sciences software and the χ
2 test. 
  The unqualified samples were classified on the basis of the 
nature of the sample, causes of disqualification, and the depart-
ments sending the samples. We analyzed the monthly rate of 
generation of unqualified samples from January 2010. We then 
uploaded this data on the website of the hospital so that the 
clinical departments could access it every month. We observed 
which department sent the most unqualified samples in a cer-
tain month and accordingly planned training programs for the 
nurses of that department. We met the clinical staff regularly to 
ensure timely and efficient communication with the staff and 
discussed and created appropriate training programs for them. 
RESULTS
We plotted the data for these 2 yr on a chart. The chart showed 
an overall substantial decrease in the processing time for sam-
ples at our clinical laboratory (Fig. 1). We observed a significant 
difference in the rate of generation of unqualified samples be-
tween 2009 and 2010 (P<0.05). A total of 1,051 unqualified 
samples were collected (603 intervention-group samples in 2009 
and 448 control-group samples in 2010). The total rate of gener-
ation of unqualified samples was 0.26% in 2009 and 0.13% in 
2010 (P<0.001). The most frequent cause of generation of un-
qualified samples was improper sample collection in microbio-
logical analysis (1.01%), complete blood count (0.38%), and co-
agulation analysis (0.57%) (Table 1). In both the intervention 
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and control groups, the following factors were responsible for 
the generation of unqualified samples: hemolysis, clotting of 
blood samples collected for complete blood count analysis, in-
sufficient sample volume, or improper sample collection meth-
ods (Fig. 2). The results of the χ
2 test showed that the rate of 
generation of each type of unqualified sample was significantly 
lower in 2010 than in 2009 (P<0.001). Thus, improper sample 
collection played a major role in the generation of unqualified 
samples.
DISCUSSION
In the age of evidence-based medicine, the results of clinical 
laboratory testing are integral to clinical decision-making and fa-
cilitate diagnosis and monitoring of therapy and prediction of 
the clinical outcome. Because of the increasing demands for 
laboratory assessments and the requirement of standardization 
in clinical laboratories, the primary goal should be to ensure 
highly efficient communication between the clinical staff and 
patients. The balance between efficiency and quality is emerg-
ing as a strategic goal. Since the initiation of accreditation pro-
cedures, quality control measures are being gradually estab-
lished in clinical laboratories around the world. Laboratory tech-
nicians have strived to make diagnostic practices safe, effective, 
patient-centered, timely, and fair; decreasing the errors in clini-
cal laboratory practices is one of the most important factors in 
achieving these objectives [11-15].
  Lundberg’s brain-to-brain loop provides a comprehensive rep-
resentation of the entire testing process, which is divided into 
pre-analytical, analytical, and post-analytical phases [15]. The 
clinical laboratories alone are responsible for the analytical phase, 
whereas the pre-analytical phase involves laboratories, clinicians, 
patients, and many other factors associated with data entry, 
specimen collection, and transport. Previous studies have sys-
tematically addressed many issues associated with pre-analyti-
cal variability, such as patient identification, specimen rejection, 
and contamination of blood/urine/sputum/stool culture. In order 
to achieve improvements in quality and reduce errors, it is nec-
essary to study the pre-analytical process as a whole. To this end, 
clinical laboratories should map the pre-analytical phase in its 
entirety, identify factors that can cause unnecessary variability 
and lead to errors in laboratory tests, and finally, find ways to ei-
ther remove or correct these errors. Significant improvements in 
quality management can be achieved through efforts directed at 
the phases described above (Fig. 1, Table 1). 
  In our laboratory, the review of unqualified samples in 2009 
recorded on special forms helped detect the incidence rate of 
sample rejection. It must have been rather difficult for the labo-
ratory staff and clinicians to promptly identify the source of these 
Fig. 2. Comparison of the types of unqualified samples generated in 
2009 and 2010. Significant decrease in the proportion of unquali-
fied samples was observed in 2010 compared to 2009 (P<0.001).
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Table 1. Distribution of unqualified samples from inpatients in the clinical laboratory in 2009 and 2010
Sample
type
Total No.
received
No. of unqualified
samples in 2009
Rate of generation
of unqualified samples
Total No.
received
No. of unqualified
samples in 2010
Rate of generation
of unqualified samples
CBC 95,417 360 0.38% 125,590 180 0.14%*
Urine 39,313 70 0.18% 40,280 58 0.14%*
Stool 11,037 33 0.30% 17,084  35 0.20%*
Coagulation 35,129 200 0.57% 43,033 170 0.04%*
Microbiology 14,862 150 1.01% 18,320 45 0.20%*
Serum 154,851 100 0.06% 204,542 100 0.05%*
Total 350,609 913  0.26% 448,849 588 0.13%
*P<0.05: 2010 vs. 2009.
Abbreviation: CBC, complete blood count.Lai X, et al.
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unexpected results, and misinterpretation would have had a 
considerable impact on the well-being of the patients [16]. There-
fore, in January 2009, we initiated a monthly program for moni-
toring the unqualified samples, and analyzed the causes for 
generation of these samples. In early 2009, we sent the monthly 
information to every clinical department through the hospital 
website. The clinical laboratory communicated with the head 
nurse of the department showing the most number of unquali-
fied samples, and helped the nurses and workers or even the 
physicians obtain the samples in a correct way. In addition, an 
education group comprising the laboratory staff from each sub-
division started to train the individuals involved in collection and 
transmission of the samples [17]. Simultaneously, we also es-
tablished the importance of timely and effective communication 
with the clinical staff, which helps reduce unnecessary errors 
and obtain the required process efficiency. The rates of genera-
tion of unqualified samples decreased from 0.26% in 2009 to 
0.13% in 2010, and the lowest rate was observed in May and 
October in the 2 yr (Fig. 1). We train the new employees every 
May or October, which showed a reduction in the rate of gener-
ation of unqualified samples in the 2 yr.
  The main reasons for generation of unqualified samples have 
been described previously (Fig. 2). The most common reasons 
were insufficient sample volume and clotting of the samples. To 
avoid such situations during sample collection, constant training 
of clinical nurses is necessary. Therefore, continuous improve-
ments in the pre-analytical phase are very essential. 
  In conclusion, long-term monitoring of unqualified samples 
as performed in our study will result in improvements in the lab-
oratory practices and reduction in the rate of generation of un-
qualified samples. Monitoring programs in all the areas of clini-
cal laboratory will help maintain the quality standards in labora-
tory practices.
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